WallStreetZenWallStreetZen

NASDAQ: TSBX
Turnstone Biologics Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their TSBX stock forecasts and price targets.

Forecast return on equity

Is TSBX forecast to generate an efficient return?

Company
-37.05%
Industry
140.86%
Market
89.98%
TSBX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TSBX forecast to generate an efficient return on assets?

Company
-26.82%
Industry
32.43%
TSBX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TSBX earnings per share forecast

What is TSBX's earnings per share in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.69
Avg 2 year Forecast
-$0.51
Avg 3 year Forecast
-$0.33

TSBX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TSBX$0.34N/AN/A
HCWB$5.45$35.00+542.20%Strong Buy
SLXN$0.88$5.00+471.43%Strong Buy
SNSE$0.30$4.33+1,344.33%Buy
CHRO$1.23N/AN/A
View Top Biotech Stocks

Turnstone Biologics Stock Forecast FAQ

What is TSBX's earnings growth forecast for 2025-2027?

(NASDAQ: TSBX) Turnstone Biologics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.61%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.32%.

Turnstone Biologics's earnings in 2025 is -$63,014,000.On average, 1 Wall Street analyst forecast TSBX's earnings for 2025 to be -$15,966,841, with the lowest TSBX earnings forecast at -$15,966,841, and the highest TSBX earnings forecast at -$15,966,841. On average, 1 Wall Street analyst forecast TSBX's earnings for 2026 to be -$11,801,578, with the lowest TSBX earnings forecast at -$11,801,578, and the highest TSBX earnings forecast at -$11,801,578.

In 2027, TSBX is forecast to generate -$7,636,315 in earnings, with the lowest earnings forecast at -$7,636,315 and the highest earnings forecast at -$7,636,315.

If you're new to stock investing, here's how to buy Turnstone Biologics stock.

What is TSBX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: TSBX) forecast ROE is -37.05%, which is considered weak.

What is TSBX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: TSBX) Turnstone Biologics's current Earnings Per Share (EPS) is -$2.72. On average, analysts forecast that TSBX's EPS will be -$0.69 for 2025, with the lowest EPS forecast at -$0.69, and the highest EPS forecast at -$0.69. On average, analysts forecast that TSBX's EPS will be -$0.51 for 2026, with the lowest EPS forecast at -$0.51, and the highest EPS forecast at -$0.51. In 2027, TSBX's EPS is forecast to hit -$0.33 (min: -$0.33, max: -$0.33).

What is TSBX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: TSBX) forecast ROA is -26.82%, which is lower than the forecast US Biotechnology industry average of 32.43%.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.